SCHEMBL13636170

SCHEMBL13636170

C=CCN1CCN(C(=C)COc2cccc(Cl)c2Cl)CC1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
ADRA2A P08913 1/20 0.44
ADRA2B P18089 1/20 0.44
ADRA2C P18825 1/20 0.44
KMT2A Q03164 3/20 0.43
GAA P10253 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
MAPK10 P53779 4/20 0.39
MAPK8 P45983 2/20 0.39
KDM4E B2RXH2 1/20 0.39
MEN1 O00255 2/20 0.39
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
SIGMAR1 Q99720 1/20 0.38
POLB P06746 1/20 0.38
LMNA P02545 1/20 0.38
TP53 P04637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4382870 0.88 KMT2A (0.54) ALDH1A1SMN1; SMN2KMT2AGAAL3MBTL1
SCHEMBL2782099 0.70 DRD2 (0.61) ADRA2AADRA2BADRA2C
SCHEMBL19030101 0.69 TP53 (0.46) ALDH1A1SMN1; SMN2KMT2AGAAL3MBTL1
SCHEMBL5061576 0.68 POLB (0.55) ALDH1A1SMN1; SMN2ADRA2AKMT2AL3MBTL1
SCHEMBL4380515 0.68 KMT2A (0.60) ALDH1A1SMN1; SMN2KMT2AGAAMEN1
SCHEMBL4383577 0.68 ALDH1A1 (0.65) ALDH1A1SMN1; SMN2KMT2AL3MBTL1KDM4E
SCHEMBL11179875 0.68 HTR2C (0.47) ALDH1A1SMN1; SMN2ADRA2AADRA2BADRA2C
SCHEMBL4378935 0.67 NPC1 (0.51) ALDH1A1SMN1; SMN2KMT2AMEN1NPC1
SCHEMBL13603900 0.66 TP53 (0.44) ALDH1A1SMN1; SMN2KMT2AGAAL3MBTL1
SCHEMBL5486856 0.66 ALDH1A1 (0.69) ALDH1A1SMN1; SMN2KMT2AGAAL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1421071-B1 SUBSTITUTED PIPERAZINE AND DIAZEPANE DERIVAIVES AS HISTAMINE H3 RECEPTOR MODULATORS HIGH POINT PHARMACEUTICALS LLC (US) 2009-11-18 EP disclosed